Company / Profit Margin
Ginkgo Bioworks Holdings, Inc. Profit Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-183.8%
FY2025
5-year range
-583.1% / -183.8%
FY2021-FY2025
Trend
+23.7%
vs FY2024
Sector context
#106 of 143
Health Care
What the data says
At -183.8%, Ginkgo Bioworks Holdings, Inc.'s profit margin ranks #106 of 143 in the Health Care sector. Profit Margin has increased for 4 consecutive years, from -583.1% in FY2021 to -183.8% in FY2025.
Based on SEC 10-K filings.
-183.8% in FY2025 with a 5-year CAGR of -18.7%.
Improved from -355.1% to -183.8% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +256.8pp
- 5-Year Change
- -18.7pp
- 10-Year Change
- -
Sector benchmark
#106 of 143 in Health CareTop 74% of 143This company -183.8% Sector average -899.4%
▼
+79.6% above sector average
Key checks
Key Insights
- Ginkgo Bioworks Holdings, Inc.'s profit margin has grown for 4 consecutive years.
- In FY2025, profit margin increased 23.7% year-over-year.
- Currently 715.6pp above the Health Care sector average.
- Peak profit margin was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -183.8% | +23.7% |
| FY2024 | -240.9% | +32.1% |
| FY2023 | -355.1% | +19.4% |
| FY2022 | -440.6% | +24.4% |
| FY2021 | -583.1% | -253.1% |
| FY2020 | -165.2% | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026